NCT05949632 2025-08-03
A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors
Incyte Corporation
Phase 1/2 Terminated
Incyte Corporation
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Centre Hospitalier Régional d'Orléans